China (Mainland)
Chloramphenicol CAS NO.56-75-7
- Min.Order: 0 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
- Product Details
Keywords
- Acetamide, 2, 2-dichloro-N-[2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- , [R-(R*,R*)]-
- Tega-Cetin
- Tevcosin
Quick Details
- ProName: Chloramphenicol
- CasNo: 56-75-7
- Molecular Formula: C11H12Cl2N2O5
- Application: Descriptions. Granisetron injection is...
- DeliveryTime: 1 MONTHS AFTER PAYMENT
- PackAge: 25KG/BAG
- Port: Any port in China
- ProductionCapacity: 1000 Milligram/Day
- Purity: 60%
- Transportation: AIR/SEA
- LimitNum: 0 Kilogram
- Voluntary Standards: USP/BP
Superiority
Gemcitabine hydrochloride is a new synthetic difluoronucleoside anti-metabolic anti-tumor drug, developed by Eli Lilly Company, in 1995 in South Africa, Sweden, the Netherlands, Australia and other countries approved for the market, in 1996 the United States Food and Drug Administration (FDA) approved clinical use in the treatment of non-small cell lung cancer and pancreatic cancer first-line treatment. The main manufacturers of gemcitabine hydrochloride in China are Jiangsu Hausen Pharmaceutical Co., LTD., Harbin Yuheng Pharmaceutical Co., LTD.
Details
Gemcitabine hydrochloride is a new synthetic difluoronucleoside anti-metabolic anti-tumor drug, developed by Eli Lilly Company, in 1995 in South Africa, Sweden, the Netherlands, Australia and other countries approved for the market, in 1996 the United States Food and Drug Administration (FDA) approved clinical use in the treatment of non-small cell lung cancer and pancreatic cancer first-line treatment. The main manufacturers of gemcitabine hydrochloride in China are Jiangsu Hausen Pharmaceutical Co., LTD., Harbin Yuheng Pharmaceutical Co., LTD.